Differential toxic effects of methamphetamine (METH) and methylenedioxymethamphetamine (MDMA) in multidrug-resistant (mdr1a) knockout mice

Brain Research

Volumn 769, Issue 2, 1997, Pages 340-346

  Mann, Hema ^a   Ladenheim, Bruce ^a   Hirata, Hiroshi ^a   Moran, Timothy H ^b   Cadet, Jean Lud ^a  

^a NIDA Addiction Research Center   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bloo d brain barrier; Cancer; Dopamine; Methamphetamine; Methylenedioxymethamphetamine; Neurotoxicity; Nucleus accumbens; P glycoprotein; Striatum

Indexed keywords

3,4 METHYLENEDIOXYAMPHETAMINE; GLYCOPROTEIN P; METHAMPHETAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD BRAIN BARRIER; CELL MEMBRANE RESISTANCE; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; DRUG EFFECT; GENE DISRUPTION; MOUSE; MULTIDRUG RESISTANCE; MULTIGENE FAMILY; NEUROTOXICITY; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; PROTEIN DOMAIN;

ANIMALS; BINDING SITES; CORPUS STRIATUM; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; GENES, MDR; MALE; METHAMPHETAMINE; MICE; MICE, KNOCKOUT; MICE, MUTANT STRAINS; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; NUCLEUS ACCUMBENS; SEROTONIN AGENTS;

EID: 0030832634     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(97)00754-3     Document Type: Article

References (36)

1. Ali S.F., Newport G.D., Holson R.R., Slikker W. Jr., Bowyer J.F. Low environmental temperatures or pharmacologic agents that produce hypothermia decrease methamphetamine neurotoxicity in mice. Brain Res. 658:1994;32-38.
2. Beckett A.H., Moffat A.C. Correlation of partition coefficient in n-heptane-aqueous systems with buccal absorption data for series of amines and acids. J. Pharm. Pharmacol. 21:1969;144S-150S.
3. Cadet J.L., Sheng P., Ali S., Rothman R., Carlson E., Epstein C.J. Attenuation of methamphetamine-induced neurotoxicity in copper/zinc superoxide dismutase transgenic mice. J. Neurochem. 62:1994;380-383.
4. Cadet J.L., Ladenheim B., Hirata H., Rothman R.B., Ali S., Carlson E., Epstein C., Moran T.H. Superoxide radicals mediate the biochemical effects of methelenedioxymethamphetamine (MDMA): evidence from using Cu-Zn-superoxide dismutase transgenic mice. Synapse. 21:1995;169-176.
5. Chen C., Chin J.E., Ueda K., Clark D.P., Pastan I., Gottesman M.M., Robinson I.B. Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug resistant human cells. Cell. 47:1986;381-389.
6. Commins D.L., Vosmer G., Virus R.M., Woolverton W.L., Schuster C.R., Seiden L.S. Biochemical and histological evidence that methylenedioxymethamphetamine (MDMA) is toxic to neurons in rat brain. J. Pharmacol. Exp. Ther. 241:1987;338-345.
7. Devault A., Gros P. Two members of the mouse gene family confer multidrug resistance with overlapping but distinct drug specificities. Mol. Cell. Biol. 10:1990;1652-1653.
8. Endicott J.A., Ling V. The biochemistry of P-glycoprotein mediated multidrug resistance. Annu. Rev. Biochem. 58:1989;137-171.
9. Fischer J.F., Cho A.K. Chemical release of dopamine from striatal homogenates: evidence for an exchange diffusion model. J. Pharmacol. Exp. Ther. 208:1979;203-209.
10. A. Goldstein, L. Aronow, S.M. Kalman (Eds.), Principles of Drug Action. The basis of Pharmacology, 2nd edn., John Wiley, New York, 1974, pp. 227-300.
11. Goldstein G.W., Betz A.L. The blood-brain barrier. Sci. American. 225:1986;70-79.
12. Gottesman M.M., Pastan I. Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu. Rev. Biochem. 62:1993;385-427.
13. Gros P., Croop J., Housman D. Mammalian multidrug resistance gene: complete cDNA sequence indicates strong homology to bacterial transports. Cell. 47:1986;371-380.
14. Gros P., BenNeriah Y., Croop J., Housman D.E. Isolation and expression of a complementary DNA that confers multidrug resistance. Nature. 323:1986;728-731.
15. Gros P., Raymond M., Bell J., Housman D. Cloning and characterisation of a second member of the mouse mdr gene family. Mol. Cell. Biol. 8:1988;2770-2778.
16. Hirata H., Ladenheim B., Rothman R.B., Epstein C., Cadet J.L. Methamphetamine-induced serotonin neurotoxicity is mediated by superoxide radicals. Brain Res. 677:1995;345-347.
17. Hirata H., Ladenheim B., Carlson E., Epstein C., Cadet J.L. Autoradiographic evidence for methamphetamine-induced striatal dopaminergic loss in mouse brain: attenuation in CuZn-superoxide dismutase transgenic mice. Brain Res. 714:1996;95-103.
18. Hotchkiss A.J., Gibb J.W. Long term effects of multiple doses of methamphetamine on tryptophan hydroxylase and tyrosine hydroxylase activity in rat brain. J. Pharmacol. Exp. Ther. 214:1980;257-262.
19. Hsu S.I., Lothstein L., Horwitz S.B. Differential overexpression of the three mdr gene family members in multidrug-resistant J74.2 mouse cells. J. Biol. Chem. 264:1989;12053-12062.
20. Johnson M., Stone D.M., Hanson G.R., Gibb J.W. Role of the dopaminergic nigrostriatal pathway in methamphetamine-induced depression of the neostriatal serotonergic system. Eur. J. Pharmacol. 135:1987;231-234.
21. 3H]cyanoimipramine autoradiography. Brain Res. 505:1989;123-129.
22. Logan B.J., Laverty R., Sanderson W.D., Yee Y.B. Differences between rats and mice in MDMA (methylenedioxymethylamphetamine) neurotoxicity. Eur. J. Pharmacol. 52:1988;227-234.
23. Mack F., Bonisch H. Dissociation constants and lipophilicity of catecholamines and related compounds. Naunyn-Schmiedeberg's Arch. Pharmacol. 310:1979;1-9.
24. O'Callaghan J.P., Miller D.B. Neurotoxicity profiles of substituted amphetamines in the C57BL/67 mouse. J. Pharmacol. Exp. Ther. 270:1994;741-751.
25. Ricaurte G.A., Schuster C.R., Seiden L.S. Long-term effects of repeated methamphetamine administration on dopamine and serotonin neurons in the rat brain: regional study. Brain Res. 193:1980;153-163.
26. Schinkel A.H., Roelofa M.E.M., Borst P. Characterization of the human MDR3 P-glycoprotein and its recognition by P-glycoprotein specific monoclinal antibodies. Cancer Res. 51:1991;2628-2635.
27. Schinkel A.H., Smit J.J.M., van Tellingen O., Beijnen J.H., Wagenaar E., van Deemta L., Mol C.A.A.M., van der Valk M.A., Robanus-Manndag E.C., te Riele H.P.J., Berns A.J.M., Borst P. Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and the increased sensitivity to drugs. Cell. 77:1994;491-502.
28. Schinkel A.H., Wagenaar E., van Deemter L., Mol A.A.C., Borst P. Absence of mdr1a P-glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin and cyclosporin A. J. Clin. Invest. 96:1995;1698-1705.
29. Schmidt C.J. Neurotoxicity of the psychedelic amphetamine, methylene dioxymethamphetamine. J. Pharmacol. Exp. Ther. 240:1987;1-7.
30. C]methamphetamine in a monkey brain. Nucl. Med. Biol. 22:1995;321-324.
31. Sonsalla P.K., Nicklas W.J., Heikkila R.E. Role for excitatory amino acids in methamphetamine-induced dopaminergic toxicity. Science. 243:1989;398-400.
32. Stone D.M., Hanson G.R., Gibb J.W. Differences in the serotonergic of methylenedioxymethamphetamine in mice and rats. Neuropharmacology. 26:1987;1657-1661.
33. Ueda K., Cardarelli C., Gottesman M.M., Pastan I. Expression of a full-length cDNA for the human 'mdr1' gene confers resistance to colchicine, doxorubicin and vinblastine. Proc. Natl. Acad. Sci. USA. 84:1987;3004-3008.
34. Van der Bliek A.M., Koolman P.M., Schneider C., Borst P. Sequence of mdr3 cDNA encoding a human P-glycoprotein. Gene. 71:1988;401-411.
35. Wagner G.C., Ricaurte G.A., Seiden L.S., Schuster C.R., Miller R.J., Westley J. Long-lasting depletions of striatal dopamine and loss of dopamine uptake sites following repeated administration of methamphetamine. Brain Res. 181:1980;151-160.
36. Zaczek R., Coyle J.T. Rapid and simple method for measuring biogenic amine and metabolites in brain homogenates by HPLC-electrochemical detection. J. Neural Transm. 53:1982;1-5.